Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases

Authors

Jun-Xiang Zhang, George Washington University
Da-Qiang Li, George Washington University
Aiwu Ruth He, Georgetown University
Mona Motwani, George Washington UniversityFollow
Vasilis Vasiliou, University of Colorado Denver
Jeyanthy Eswaran, George Washington University
Lopa Mishra, University of Texas
Rakesh Kumar, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

6-2012

Journal

Hepatology

Volume

Volume 55, Issue 6

Inclusive Pages

1840-1851

Keywords

Carcinoma; Hepatocellular--drug therapy; Histone Deacetylase Inhibitors--pharmacology; Hydroxamic Acids--pharmacology; Liver Neoplasms--drug therapy; Phthalazines--pharmacology; Piperazines--pharmacology; Poly(ADP-ribose) Polymerases--antagonists & inhibitors

APA Citation

Zhang, J., Li, D., He, A., Motwani, M., Vasiliou, V., Eswaran, J., Mishra, L., & Kumar, R. (2012). Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (adp-ribose) polymerases. Hepatology, 55(6), 1840-1851.